Vitamin B12 and other nutrients on GLP-1 medication: what is known, and what is not

When the medication quiets your appetite, the plate gets smaller. For many people, that is the relief they were hoping for. It also raises a fair question: if you are eating less, are you still getting enough of the vitamins and minerals your body runs on?

The honest answer is that researchers are asking the same question, and direct evidence is still limited. Here is what the published work says, where it stops, and what to bring to your prescriber.

Why smaller portions raise the question

A 2026 paper in Clinical Nutrition ESPEN notes that GLP-1 and dual GIP/GLP-1 medicines produce weight loss mainly by reducing appetite and energy intake. A 2026 scoping review on surgical care found GLP-1 treatment linked to reduced energy intake and inadequate protein intake. Less food overall can leave less room for the foods that carry nutrients, and researchers have started writing about micronutrient monitoring in the GLP-1 era as well.

What the research says about micronutrients

A 2026 narrative review in Clinical Obesity states that GLP-1 receptor agonists such as semaglutide, liraglutide and tirzepatide may predispose users to micronutrient deficiencies. Notice the word "may". That is a signal worth watching, not a measured rate.

Other papers frame it as an open question. One 2025 paper is titled "GLP-1 Receptor Agonists – Good for Body Weight, Bad for Micronutrient Status?", question mark included. Another asks whether clinicians can learn from metabolic and bariatric surgery about supplementation and monitoring. A 2026 paper in Obesity Pillars sets out mechanistic pathways, clinical signals and a monitoring framework for micronutrient risk with these medicines.

Professional bodies are responding with consensus-based guidance. Four US-based professional societies published a joint advisory on nutritional priorities to support GLP-1 therapy for obesity in 2025 (DOI 10.1002/oby.24336). In Europe, EASO, EFAD and ECPO issued a consensus statement on nutritional, functional and psychological considerations for incretin-based therapies in 2026. A separate expert consensus, built with a modified Delphi method, says plainly that because direct evidence is limited, consensus-based recommendations are needed.

What none of these sources gives us is a figure for how often deficiencies actually happen on GLP-1 medication.

What about vitamin B12 specifically

This is where the evidence is thinnest. None of the sources we reviewed shows that GLP-1 medication itself causes B12 deficiency, or how often it might. What the literature does describe is a separate, known link: papers on diabetes care discuss metformin's effect on vitamin B12 absorption. If you take metformin as well, that is worth raising with your prescriber.

The NHS sets out the usual causes of B12 deficiency. In the UK, the most common is pernicious anaemia, an autoimmune condition in which the immune system attacks the stomach cells needed to absorb B12. Low intake is uncommon, but can result from long-term poor eating, or from vegan eating without B12 supplements or fortified foods. Some medicines, including certain anticonvulsants and proton pump inhibitors, can reduce absorption. Deficiency is also more common in older adults.

Signs worth mentioning

The NHS lists symptoms of B12 or folate deficiency including tiredness, low energy, pins and needles, a sore red tongue, mouth ulcers, muscle weakness, vision problems, mood changes and difficulties with memory. Some of these can occur even without anaemia.

Diagnosis usually relies on symptoms and a blood test, and the NHS stresses that early treatment matters, because some nervous system damage can be permanent. If you notice any of these, talk to your prescriber about whether a test makes sense for you, rather than guessing.

Making a smaller plate count

Without a number to chase, the practical idea is this: when portions shrink, make room for foods that carry nutrients. The NHS lists B12 sources as meat, fish, eggs, dairy and fortified foods, and folate sources as broccoli, Brussels sprouts and peas. One narrative review on supplement considerations during GLP-1 treatment discusses multivitamins for micronutrient insufficiencies. Whether any supplement fits you is a conversation for your prescriber.

Protein is its own topic. If muscle is on your mind, read GLP-1 and muscle mass: protein, training and sarcopenia and how to protect muscle on GLP-1 medication, or find a starting point to discuss with your care team using the Gila protein calculator.

Key Takeaways

• GLP-1 medicines lead to weight loss largely by reducing appetite and energy intake, so nutrient adequacy is a fair question to ask.
• A 2026 review says these medicines may predispose users to micronutrient deficiencies, but experts also note that direct evidence is limited.
• None of the sources we reviewed shows that GLP-1 medication causes B12 deficiency or how often; metformin's effect on B12 absorption is a separate, known link.
• B12 deficiency symptoms include tiredness, pins and needles and memory difficulties, and diagnosis usually relies on symptoms and a blood test.
• Tests and supplements are a conversation with your prescriber.

Keep what the medication starts

Editor: Sezen Soykut